1. Introduction {#sec1}
===============

A large fraction of all DNA damages are formed at 2′-deoxyguanosines (dGs).^[@ref1]^ Of the four common nucleosides in DNA, oxidation takes place most easily at dG residues, giving rise to a variety of products including 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxo-dG) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref2],[@ref3]^ 8-Oxo-dG is more susceptible to oxidation than dG, and it generates a number of secondary oxidation products.^[@ref4],[@ref5]^ The pathway leading to 8-oxo-dG is believed to involve a C8-hydroxyl radical, which also forms Fapy·dG ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref6]^

![Structures of small and common ring-opened dG lesions.](tx-2016-00285a_0002){#fig1}

Methylating and ethylating agents preferentially react at N7, but they also alkylate *O*^6^ of dG, and the fraction of alkylation at *O*^6^ increases with "harder" electrophiles.^[@ref7],[@ref8]^ The N7-Methyl-dG (N7-Me-dG) adduct is unstable, which either depurinates to form an abasic site or undergoes ring opening to generate MeFapy·dG ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Interestingly, a vast majority of the bulky adducts are formed at either N7 or the exocyclic *N*^2^ position of dG. The unstable dG-N7 adducts formed by the metabolically activated aromatic amines and nitro compounds rearrange to stable dG-C8 adducts,^[@ref9]^ while minor adducts at the *N*^2^ position of dG have also been isolated.^[@ref10],[@ref11]^ In contrast, a majority of the metabolically activated epoxides of polycyclic aromatic hydrocarbons (PAHs) form the dG-*N*^2^ adducts as the major products.^[@ref12]^ Metabolically activated aflatoxin B~1~, however, forms the primary dG-N7 adduct, which undergoes ring opening to a stable formamidopyrimidine (Fapy) derivative.^[@ref13]^ Like the PAH epoxides, the antitumor agent mitomycin C (MC) containing an aziridine ring preferentially forms the dG-*N*^2^ adducts.^[@ref14]^ The genotoxicity and mutagenicity of many of these adducts have been investigated in prokaryotic and eukaryotic cells for the last three decades. Replication of these DNA lesions do not follow a unifying mechanism, and each lesion exhibits a characteristic mutational spectrum. However, increasingly it became clear that the mutational signature of a DNA lesion is directly related to the identity of the DNA polymerase(s) that bypass it and the mechanism of its nucleotide insertion and extension, though additional factors such as DNA sequence context play a role as well.

A human cell contains at least 17 different DNA polymerases (pols) to perform different functions of the cell, which include DNA replication of undamaged and damaged DNA, replication as part of various DNA repair pathways, recombination, telomere maintenance, and other tasks.^[@ref15],[@ref16]^ On the basis of sequence homology, pols have been divided into seven families (A, B, C, D, X, Y, and RT), of which C family pols were only found in prokaryotes. In eukaryotes, the B-family enzymes are important since pol ε and pol δ of this family carry out a large fraction of nuclear DNA replication, whereas pol α is involved in initiation and priming. These three pols are essential for DNA replication in eukaryotes. In the current model of DNA replication, pol ε carries out a majority of leading strand DNA replication of the undamaged genome, whereas pol δ primarily replicates the lagging strand. However, this model has recently been challenged, and data supporting the involvement of pol δ in both leading and lagging strand replication have been presented.^[@ref17]−[@ref19]^

The discovery of translesion synthesis (TLS) DNA pols in the 1990s invigorated the area of replication of DNA lesions, and since then, numerous articles have been published on the catalytic and noncatalytic roles of these pols in the context of damaged DNA replication.^[@ref20]^ Lesion bypass is carried out principally by the Y-family pols, although X- and B-family pols are also frequently involved. Like the replicative pols, these pols possess right-handed topology with the active site located in the "palm" domain, except that the active site is much larger in order to accommodate the DNA lesions. Unlike the replicative pols, in which the finger and thumb domains ensure correct pairing with the incoming nucleotide, they are shorter and make little interaction with the template and the incoming dNTP, thereby reducing the pol's ability to discriminate the accuracy of nucleotide insertion. A little finger domain assists to stabilize the Y-family pol on DNA. An important aspect of the Y-family pols and pol ζ of the B-family is that they lack the 3′--5′ proofreading function, making them error-prone but letting them carry out TLS.

From the perspective of TLS, DNA lesions can be broadly divided between weak and strong replication blocks. Small DNA lesions such as *O*^6^-Me-dG and 8-oxo-dG stall but do not completely stop DNA synthesis, whereas most bulky DNA lesions, such as the adducts formed by the PAHs and aromatic amines, are much stronger replication blocks and require the assistance of TLS pols to bypass. The current paradigm on TLS is as follows. When a processive DNA pol encounters a blocking lesion, the pol dissociates, and a TLS pol binds to the DNA and incorporates a dNTP opposite the lesion. In many cases, the same pol continues elongation for a few more bases before dissociating, while in other occasions this TLS pol is replaced by another TLS pol for the elongation steps. TLS pols exhibit higher rate of errors on unmodified templates and are also highly error-prone when bypassing most DNA lesions. Soon after bypassing the lesion, the processive pol returns to continue DNA synthesis. However, the actual process of pol switching is still speculative, and many related questions remain unanswered at the present time.^[@ref21]−[@ref23]^ During cellular replication, the fork utilizes many proteins, including DNA pol, helicase, and single strand binding proteins, to name a few. A prerequisite for TLS is the Rad6/Rad18-mediated monoubiquitination of proliferating cell nuclear antigen (PCNA) at the highly conserved lysine K164.^[@ref24]−[@ref26]^ Y-family pols contain ubiquitin-binding domains that confer affinity to monoubiquitinated PCNA.^[@ref27]−[@ref31]^ In mammalian cells, a Rad18 orthologue is involved in PCNA ubiquitination.^[@ref32]^ In addition, two human Rad5-related proteins, SNF2 histone-linker PHD-finger RING-finger helicase (SHPRH) and helicase-like transcription factor (HLTF), transform monoubiquitinated PCNA into the polyubiquitinated form.^[@ref30],[@ref33]−[@ref35]^ Additional DNA damage response pathways, including SHPRH/HLTF-mediated template switching, also depend on PCNA ubiquitination. So, when replication by pol δ or pol ε is blocked by a DNA lesion, PCNA is monoubiquitinated by the Rad6-Rad18 protein complex and promotes the switch to a TLS pol at the damage site ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Evidently, the activity of the TLS pols must be tightly regulated so that they only gain access to genomic DNA when there is DNA damage. Indeed, regulation of TLS also involves ubiquitination of the TLS pols. For example, monoubiquitination of pol η inhibits its interaction with PCNA, thereby preventing its activity on undamaged DNA, but monoubiquitination is downregulated by the DNA damaging agents.^[@ref36],[@ref37]^ This mechanism allows optimal availability of nonubiquitinated and active pol η following DNA damage. Post-translational regulation of these proteins is an area where much emphasis has recently been placed.^[@ref36]−[@ref39]^ Despite the predominant role of these bypass pols in TLS, it is also worth noting that there is evidence that replicative pols (such as pol δ) may take part in some TLS events.^[@ref40]^

![Abridged TLS scheme using pol η as an example of the TLS polymerase.](tx-2016-00285a_0003){#fig2}

2. TLS of Small and Ring-Opened dG Lesions {#sec2}
==========================================

2.1. 8-Oxo-dG {#sec2.1}
-------------

Oxidative stress generates many different DNA lesions, but 8-oxo-dG is the most widely studied DNA lesion formed by reactive oxygen species such as hydroxyl radicals ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref2]^ 8-Oxo-dG does not strongly block DNA synthesis in eukaryotic cells, as reflected by the number of progeny derived from replication of singly adducted vectors.^[@ref41],[@ref42]^ Crystallographic studies using a high fidelity pol indicated that 8-oxo-dG adopts *syn* conformation at the preinsertion stage and pairs preferentially with adenine via Hoogsteen base pairing in the pol active site.^[@ref43]^ However, *in vitro* experiments using yeast pol δ showed that only about 10% TLS takes place in the absence of any accessory proteins.^[@ref44]^ Even in the presence of PCNA, steady-state reactions of calf-thymus DNA pol δ were decreased by a factor of 12 for dATP and dCTP incorporation opposite 8-oxo-dG. The major DNA pols in mammalian cells, pol α, pol δ, and pol ε extend an 8-oxo-G:A pair more efficiently than the correct 8-oxo-G:C pair.^[@ref44],[@ref45]^*In vitro* experiments showed that pol ζ is inefficient in nucleotide insertions opposite 8-oxo-dG, but it can efficiently extend from the nucleotides inserted opposite it by pol δ.^[@ref46]^ Yet, in human cells TLS of 8-oxo-dG is largely error-free (mutation frequency (MF) ∼1% in duplex DNA and 4--20% in single stranded DNA).^[@ref47]−[@ref49]^ Several repair systems, including base excision repair and mismatch repair, excise 8-oxo-dG from duplex DNA, justifying low MF, but most repair systems are inefficient in 8-oxo-dG repair in single-stranded DNA.^[@ref50]−[@ref52]^ One might wonder why the TLS of 8-oxo-dG in single-stranded DNA is mostly error-free. The answer came from *in vitro* and cellular experiments, which determined a crucial role of pol λ, an X-family enzyme, in 8-oxo-dG bypass. The preference for dCTP incorporation over either dATP or dGTP incorporation opposite 8-oxo-dG is 12-fold by pol λ.^[@ref45],[@ref53]^ However, it is remarkable that in the presence of the accessory proteins, human PCNA and replication protein A (RPA), correct incorporation of dCTP over other dNTPs opposite 8-oxo-dG increased to 1200-fold by pol λ.^[@ref45],[@ref53]^ In a similar vein, PCNA and RPA increased the preference for dCTP over dATP or dGTP incorporation opposite 8-oxo-dG by pol η from 2.5-fold to 68-fold.^[@ref45],[@ref53]^ On the basis of these results and additional data from mouse embryonic fibroblasts and human cell lines, it was suggested that the switch from pol δ involved pol λ and not pol β or pol η since mutations by 8-oxo-dG increased considerably in pol λ knockout or knockdown cells.^[@ref53],[@ref54]^ In yeast chromosome, however, the switch to pol η, which replicates 8-oxo-dG with an accuracy of 94%, was reported.^[@ref55]^ In the absence of pol η, accurate replication drops to 40%. DNA pol δ-interacting protein 2 (PolDIP2, also known as PDIP38) physically interacts with pol λ and increases the efficiency of elongation past 8-oxo-dG by pol λ, suggesting an important role of this protein in pol switch and elongation steps during TLS.^[@ref56]^ If pol λ (in the presence of the accessory proteins) were the only pol that bypasses 8-oxo-dG, MF would have dropped to less than 1%. The 4--20% MF, which depends on the DNA sequence context and the type of assay, in single-stranded DNA indicates, however, that in addition to pol λ, other pols bypass the lesion. In human embryonic kidney (HEK) 293T cells, depending on the DNA sequence context, we observed 38--50% increase in mutations induced by 8-oxo-dG, upon knockdown of pol λ.^[@ref57]^ It is interesting that G → T mutations were not significantly increased in pol λ knockdown cells. The increase in mutations was primarily due to an increase in dinucleotide deletions, involving the lesion and one of its neighboring bases. Others have also reported targeted one-base or small deletions in the absence of pol λ.^[@ref53]^ It appears, therefore, that pol λ prevents these deletions induced by 8-oxo-dG. However, it is unclear which pol is causing the deletion mutations. In addition to the DNA pols, an additional factor is the participation of a homologue of MutY glycosylase. MutY human homologue (MUTYH) shares 41% and 79% of sequence homology to its *E. coli* counterpart MutY and mouse homologue mMYH, respectively.^[@ref58]^ MutY removes adenine from the 8-oxo-G:A mispair, which allows another chance to incorporate C opposite 8-oxo-dG by a pol.^[@ref59]^ In a study in human lymphoblastoid cells, replication of 8-oxo-dG generated ∼14% mutants, including 6% G → T and 2% targeted single-base deletions.^[@ref60]^ Overexpression of MUTYH reduced the G → T mutations, but the deletions remained unaffected, which also suggests the role of an unidentified DNA pol in the 8-oxo-dG induced deletions. While the role of these deletions in human diseases is unknown, inherited variants of MUTYH in a family affected by colon cancers show a pattern of high G:C → T:A mutations implicating a role of unrepaired 8-oxo-dG lesions in human cancer.^[@ref61]^

2.2. Fapy·dG and MeFapy·dG {#sec2.2}
--------------------------

Fapy·dG ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) is generated at comparable levels under many conditions to 8-oxo-dG, but only a limited number of biological studies have been conducted with this lesion.^[@ref6]^ Bypass efficiency of purine-ring opened Fapy·dG is slower than 8-oxo-dG.^[@ref62]^ Like 8-oxo-dG, Fapy·dG is mutagenic inducing predominantly G → T transeversions in mammalian cells.^[@ref48],[@ref57]^ However, the MF is highly dependent on the DNA sequence context. For example, the MF of Fapy·dG in the TG\*T sequence is significantly higher than when it is located in the TG\*A sequence in both simian (COS-7) and human embryonic (293T) kidney cells.^[@ref48],[@ref57]^ In human cells, in some sequence contexts Fapy·dG is more mutagenic than 8-oxo-dG, while in others the opposite is true. The major difference between the two lesions, however, is that knockdown of pol λ reduced the level of G → T mutations induced by Fapy·dG, in contrast to an increase in MF for 8-oxo-dG.^[@ref57]^ This suggests that pol λ is involved in a significant fraction of Fapy·dG induced G → T mutations, whereas it carries out error-free bypass of 8-oxo-dG. It is interesting, however, that the level of small deletions increases upon replication of either 8-oxo-dG or Fapy·dG in human cells in which pol λ was knocked down. Unlike 8-oxo-dG, which adopts *syn* conformation to pair with adenine,^[@ref43]^ a structural study of the carbocyclic analogue of Fapy·dG by a high fidelity pol (*Bst* pol I) showed that the lesion maintains its *anti* conformation of the glycosidic bond during both error-free and error-prone replication.^[@ref63]^

Most biological assays indicate that N7-Me-dG is not mutagenic but that its ring-opened derivative MeFapy·dG ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) is mutagenic.^[@ref7],[@ref64]−[@ref68]^*In vitro* assays showed that the MeFapy·dG is a strong block to the high fidelity replicative DNA polymerases at both the insertion and the extension steps.^[@ref67]^ However, hpol η and hpol κ as well as hRev1 and ypol ζ together can carry out facile TLS. With hpol η and hpol κ, the predominant replication product is the error-free extension product, whereas hRev1 and ypol ζ together accomplish entirely error-free TLS. Up to 29% mutagenic TLS, including each of the targeted base changes and one-nucleotide deletion products, were identified from replication products generated by hpol η and hpol κ. In COS-7 cells, MeFapy·dG induces G → T mutations and single and dinucleotide deletions as do 8-oxo-dG and Fapy·dG.^[@ref68]^ However, cellular experiments in human cells analogous to Fapy·dG have not been performed with MeFapy·dG, and it would certainly be interesting to compare the replicative properties of Fapy·dG with MeFapy·dG using the same approach.

2.3. *O*^6^-Methyl-dG {#sec2.3}
---------------------

*O*^6^-Methyl-dG (*O*^6^-Me-dG) is one of the first mutagenic DNA lesions identified as a result of DNA methylation ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref69]^ It is highly mutagenic but is quickly repaired in a cell by multiple repair systems.^[@ref70]−[@ref72]^ A great deal of circumstantial evidence indicates that it plays a role in the etiology of human cancer.^[@ref73]−[@ref76]^ Using an intrachromosomal probe, ∼19% G → A mutations were detected after replication of a site-specific *O*^6^-Me-dG in Chinese Hamster Ovary cells deficient in the repair enzyme *O*^6^-alkylguanine-DNA alkyltransferase, but in repair proficient cells, mutation frequency dropped to an ∼1% level.^[@ref77]^ Like 8-oxo-dG, it allows partial bypass of several purified DNA polymerases, but pol δ is only slightly inhibited *in vitro* and inserts dCTP and dTTP equally well opposite *O*^6^-Me-dG.^[@ref78]^ However, pol α is strongly blocked one base before *O*^6^-Me-dG.^[@ref79]^*O*^6^-Me-dG also is a strong but not absolute block of human pol β, and even though hpol β inserts dTTP more efficiently than dCTP opposite the lesion, it preferentially extends the correct *O*^6^-Me-G:C pair.^[@ref80]^ In the absence of accessory proteins, the human TLS pol ι and pol κ produce mainly one-base incorporation products opposite this lesion, but hpol η is much more efficient.^[@ref78]^ Steady-state kinetic analysis showed similar efficiencies of insertion of dCTP and dTTP opposite *O*^6^-Me-dG by hpol η and hpol κ, whereas hpol ι showed a higher preference for dTTP insertion.^[@ref78]^ Genetic studies in yeast implicate both pol δ and pol η in the TLS of *O*^6^-Me-dG, even though biochemical studies suggest that hpol η is more efficient than hpol δ.^[@ref81]^ Similar to 8-oxo-dG, in yeast pol ζ is very inefficient at inserting nucleotides opposite *O*^6^-Me-dG, but it can efficiently extend from the nucleotides inserted opposite it by pol δ. As a result, the most efficient bypass can be accomplished *in vitro* when both pol δ and pol ζ were used for the TLS of templates containing *O*^6^-Me-dG.^[@ref46]^

3. TLS of Bulky dG Lesions {#sec3}
==========================

Even though this perspective is focused on dG lesions, it may be pertinent to mention investigations that established a specialized role of pol η in efficient and error-free bypass of UV light-induced *cis-syn* cyclobutane pyrimidine dimers (CPDs). This is due to pol η's unique ability to accommodate both pyrimidine residues of this bulky lesion in its active site and perform accurate and efficient TLS.^[@ref82],[@ref83]^ Pol κ and pol ζ, on the other hand, provide an alternate, albeit highly error-prone, pathway of TLS of CPDs. In the absence of pol κ and pol ζ, TLS of CPDs carried out by pol η is error-free, and mutations decrease to the background level.^[@ref84]^ Mutations in this gene (*POLH*) result in XPV, a variant type of the genetic disease, xeroderma pigmentosum, which is characterized by extreme sensitivity to UV light.^[@ref85]−[@ref87]^ No other DNA pol exhibits such a precise and dedicated role, but the main characteristics of the other bypass pols have been established. One example is the ability of pol κ in the error-free bypass of dG-*N*^2^ lesions (discussed later). The enlarged active site of pol η allows it to accommodate even the cisplatin-derived large intrastrand N7--Pt--N7 cross-linked two guanine residues and to bypass accurately.^[@ref88],[@ref89]^ Crystal structure analysis showed that to allow the lesion to fit in its active site, pol η goes through a backbone rearrangement to stabilize the lesion and incorporate dCTP opposite the two guanines.^[@ref90]^ However, it also shows that the rigid backbone of the ternary complex with pol η does not allow extension, which necessitates another TLS pol such as pol ζ to extend it.

3.1. Aflatoxin B~1~ {#sec3.1}
-------------------

The potent hepatocarcinogen aflatoxin B~1~ (AFB~1~) forms two major DNA adducts upon metabolic activation of AFB~1~ to AFB~1~-8,9-epoxide by the liver cytochrome P450 enzymes ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).^[@ref91],[@ref92]^ The primary DNA adduct, AFB~1~--N7-dG, is formed at the N7 position of dG.^[@ref13],[@ref93]−[@ref95]^ This adduct is chemically unstable due to the positive charge at N7, which can undergo either spontaneous depurination to generate abasic sites or ring opening to form AFB~1~--Fapy-dG ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Both these adducts are mutagenic in simian kidney (COS-7) cells when the adduct is located in a TTG\*AA sequence, but AFB~1~--Fapy-dG induces 97% mutations compared to 45% mutations by the AFB~1~--N7-dG adduct.^[@ref96],[@ref97]^ Both AFB~1~--N7-dG and AFB~1~--Fapy-dG predominantly induce G → T transversions. Interestingly, *in vitro* TLS assays showed that pol ζ bypasses AFB~1~--N7-dG in an error-free manner, whereas it is responsible for the erroneous bypass of AFB~1~--Fapy-dG. For AFB~1~--N7-dG, pol κ appears to be involved in the mutagenic bypass. Because of the importance of these adducts in human cancer, additional structural, genetic, and *in vitro* studies on the two DNA adducts in the future would certainly be of significant interest.

![Aflatoxin B~1~, its *exo* epoxide, and the major dG adducts.](tx-2016-00285a_0004){#fig3}

3.2. Benzo\[*a*\]pyrene {#sec3.2}
-----------------------

PAHs are ubiquitous in our environment, and many of them, notably those with a "bay" or "fjord" region, are highly mutagenic and carcinogenic.^[@ref12]^ The most extensively studied PAH is benzo\[*a*\]pyrene (BP), an extremely carcinogenic chemical, which upon metabolic activation binds to DNA, predominantly at the *N*^2^ position of dG ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). BP is metabolized by the mammalian monooxygenase enzymes to form the diastereomeric *anti*- and *syn*-benzo\[*a*\]pyrene 7,8-dihydrodiol-9,10-epoxide (BPDE). The metabolically activated (+)-*anti* BPDE is a potent mutagen and the most tumorigenic metabolite of BP. It is believed to be the ultimate carcinogenic form that leads to *trans-* and *cis*-dG-*N*^2^ adducts ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). The principal mutation in mammalian cells induced by the major dG adducts of BP is G:C → T:A transversion.^[@ref98]−[@ref100]^ BP adducts are strong blocks of replication by replicative pols, but the TLS pols can bypass them at varying efficiencies. *In vitro* studies using either hpol ι or hpol η showed that the BPDE dG adducts allow slow bypass, which results in a high frequency of nucleotide misincorporations.^[@ref101],[@ref102]^ In yeast, however, (±)-*anti*-BPDE mutagenesis requires pol ζ and partially involves pol η, but pol η mainly contributes to deletions and insertions of 1--3 nucleotides.^[@ref103]^ In contrast, pol κ performs accurate and reasonably efficient replication of the BPDE dG adducts. The extent of bypass drops, and mutagenesis increases significantly in human and murine cells lacking pol κ.^[@ref104]^ Pol κ's catalytic site, unlike that of pol η, can only accommodate one Watson--Crick base pair. However, it is capable of TLS of many dG-*N*^2^ adducts, including the DNA adducts formed by BP.^[@ref104]−[@ref106]^ Specifically, for the (+)-*trans-anti*-dG-*N*^2^-BPDE adduct, genetic, *in vitro* kinetics, and structural studies show that pol κ performs efficient and accurate TLS. For the mutagenic TLS, genetic evidence suggests that a non-Y family pol inserts a wrong nucleotide (dATP or dTTP) opposite the adduct but that extension is performed cooperatively by pol ζ and Rev1.^[@ref107]^ It was postulated that Rev1 recruits pol ζ via interaction with Rev7.

![Metabilic activation and the major DNA adducts formed by benzo\[a\]pyrene.](tx-2016-00285a_0005){#fig4}

Crystal structure analyses of the (+)-*trans-anti*-dG-*N*^2^-BPDE adduct showed that the active site of pol κ is opened up at the minor groove side of the primer--template complex allowing accommodation of the bulky BPDE-dG adduct.^[@ref108]^ The amino acid residues of the protein in the minor groove side of DNA stabilizes the hydrophobic BPDE ring and maintains Watson--Crick base pairing with an incoming dCTP for accurate replication.

Pol κ also bypasses many other dG-*N*^2^ adducts accurately and efficiently, which includes *N*^2^-(1-carboxyethyl)-dG and *N*^2^-furfuryl-dG as well as much bulkier adducts formed by IQ and mitomycin C (discussed in the next section).^[@ref109]−[@ref112]^

3.3. dG-*N*^2^ Adducts of IQ and Mitomycin C {#sec3.3}
--------------------------------------------

We have recently studied the minor, albeit persistent, dG-*N*^2^ adduct ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) formed by the carcinogen 2-amino-3-methylimidazo\[4,5-*f*\]quinoline (IQ), a heterocyclic aromatic amine formed during high temperature cooking of meat,^[@ref113]−[@ref115]^ and two dG-*N*^2^adducts ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}) formed by the antitumor agent, mitomycin C (MC), and its metabolite, 2--7-diaminomitosene (2,7-DAM).^[@ref14],[@ref116],[@ref117]^

![Structure of IQ and its dG adducts.](tx-2016-00285a_0006){#fig5}

![Structures of the dG-*N*^2^ adducts formed by mitomycin C and its metabolite 2,7-diaminomitosene.](tx-2016-00285a_0007){#fig6}

The dG-*N*^2^-IQ adduct was studied in the three different guanines of the *Nar*I restriction site (5′-G~1~G~2~CG~3~CC-3′). As shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, in HEK293T cells MF increases upon knockdown of only pol κ, whereas knockdown of pol η, pol ι, pol ζ, or Rev1 results in a reduction in MF. The greatest reduction in MF occurred when pol η, pol ζ, and Rev1 were concurrently knocked down. This suggests that pol κ is involved in error-free bypass of the dG-*N*^2^ adduct formed by IQ, whereas pol η, pol ζ, and Rev1 cooperatively carried out mutagenic TLS.^[@ref111]^ Similar results were obtained with the mitomycin C adducts ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), indicating that they also follow analogous mechanisms.^[@ref112]^ It was also established that with the increasing bulk of the dG-*N*^2^ adducts, the misincorporation frequency of dATP relative to dCTP increases significantly.^[@ref118]^ Taken together, there seems to be a predictable pattern of error-free and error-prone TLS of dG-*N*^2^ adducts by the TLS pols.

###### Mutation Frequency of dG-*N*^2^-IQ (in Three Different Guanines of the *Nar*I Site), dG-*N*^2^-MC, and dG-*N*^2^-2,7-DAM and Their Change in Percentages upon Knockdown of Specific Pols

  lesion              MF (%)   \% change in MF in pol η-deficient cells   \% change in MF in pol κ-deficient cells   \% change in MF in pol ι-deficient cells   \% change in MF in pol ζ-deficient cells   \% change in MF in Rev1-deficient cells   \% change in MF in (η, ζ, Rev1) deficient cells
  ------------------- -------- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ----------------------------------------- -------------------------------------------------
  dG~1~-*N*^2^-IQ     22.7     --21                                       +23                                        --12                                       --16                                       --20                                      --84
  dG~2~-*N*^2^-IQ     17       --21                                       +18                                        --18                                       --18                                       --21                                      --87
  dG~3~-*N*^2^-IQ     11       --27                                       +5                                         --15                                       --18                                       --22                                      --90
  dG-*N*^2^-MC        18       --44                                       +39                                        ND[a](#t1fn1){ref-type="table-fn"}         --33                                       ND                                        --78
  dG-*N*^2^-2,7-DAM   10       --20                                       +50                                        ND                                         --10                                       ND                                        --81

ND, not determined.

Exceptions to this rule, however, are the minor groove adducts γ-hydroxy-1,*N*^2^-propano-dG and *trans*-4-hydroxy-2-nonenal-dG, in which case pol κ is inefficient in nucleotide insertion opposite the lesion, but it efficiently acts as an extender.^[@ref119],[@ref120]^ In both these cases, pol ι can insert dCTP opposite the lesions but is inefficient in extending the G\*:C pair. In contrast, pol κ is unable to insert a nucleotide opposite these lesions, but it can extend the G\*:C pair. Thus, the sequential act of pol ι and pol κ promotes efficient and error-free TLS of these lesions. It is noteworthy that these are cyclic adducts with a covalent bond with N1 in addition to *N*^2^ of dG, suggesting that pol κ's ability to insert a nucleotide is impaired for adducts with dual linkages.

3.4. *N*-Acetyl-2-aminofluorene {#sec3.4}
-------------------------------

One of the most extensively studied DNA adduct is dG-C8-AAF ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}), the dG-C8 adduct formed by *N*-acetyl-2-aminofluorene (AAF), which induces frameshift mutation in bacteria and human cells, but in simian kidney (COS-7) cells, when the adduct is placed in a single stranded plasmid, it causes largely G → T mutations.^[@ref121]−[@ref124]^ However, in a subsequent study, also in COS-7 cells but in duplex DNA, at the third guanine of 5′-GG[G]{.ul}-3′ and 5′-GGC[G]{.ul}CC-3′ (*Nar*I site), −1 and −2 frameshift mutations, respectively, were detected.^[@ref125]^ The frameshifts also occurred in human cell-free extracts. The frameshift mutations at the 5′-GG[G]{.ul}-3′ sequence are dependent on pol η but not pol ι or pol ζ. Furthermore, this pol η-mediated erroneous pathway requires Rad18 and ubiquitination of PCNA. On the other hand, TLS is only partially dependent on pol η and Rad18 when the adduct is situated at the *Nar*I site. This indicates that the same adduct may follow different mechanisms for mutagenesis in different sequence contexts.

![Structures of the dG-C8 adducts formed by *N*-acetyl-2-aminofluorene, 1-nitropyrene, and 3-nitrobenzanthrone.](tx-2016-00285a_0008){#fig7}

The mechanism of both −1 and −2 frameshifts was suggested to follow a slipped frameshift intermediate,^[@ref126],[@ref127]^ and while most pols are inefficient in extending such an intermediate, pol η can extend them, albeit slowly.^[@ref128]^ In duplex DNA, dG-C8-AAF is known to rotate the guanine base to *syn* conformation, in contrast to an overwhelming *anti* conformation of an unmodified dG.^[@ref129],[@ref130]^ Biophysical and computational studies indicate that *syn* conformation in a base-displaced intercalated structure of the dG adduct allows formation of stable slipped intermediates.^[@ref126],[@ref130],[@ref131]^ Such intermediates, upon elongation, would cause frameshift mutations, the major types of mutations detected in bacteria^[@ref11],[@ref122],[@ref132]^ and occasionally in mammalian cells (or cell-free extracts).^[@ref125],[@ref133]^ The role of pol η in bypassing misaligned adducts has been explored, which showed that depending on the base sequence, a cytosine inserted opposite the dG-C8 lesion slips to generate a −1, −2, or −3 frameshift intermediate that pol η can continue to replicate, in spite of a bulge.^[@ref128]^ In a crystal structure study, however, pol η was able to incorporate dCTP opposite the dG-C8-AAF adduct, in which TLS occured without rotation of the adduct into the *anti* conformation, and only one hydrogen bond was formed between the lesion and dCTP.^[@ref134]^ This structural investigation recognized pol η's ability to perform error-free replication of dG-C8-AAF, in addition to its propensity to carry out frameshifts.

3.5. dG-C8 Adducts Formed by IQ, 3-Nitrobenzanthrone, and 1-Nitropyrene {#sec3.5}
-----------------------------------------------------------------------

Like the dG-*N*^2^ adducts, the roles of TLS DNA pols in bypassing the C8-dG adduct (dG-C8-IQ) ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) formed by IQ were explored at the G~1~-, G~2~-, or G~3~-positions of the *Nar*I recognition sequence after replication in HEK293T cells.^[@ref135]^ MF was the highest (50%) when the adduct was placed at G~3~, compared to 18% and 24% MF when the adduct was located at G~1~ and G~2~, respectively, inducing mainly G → T transversions at each site. MF of dG-C8-IQ was reduced in varying degrees upon siRNA knockdown of pol κ, pol ι-, pol ζ-, or Rev1-knockdown cells ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), indicating that these pols are involved in error-prone synthesis of this adduct. In contrast, MF was increased by 8--26% in pol η knockdown cells, suggesting that pol η bypasses the lesion accurately.

###### Mutation Frequency of dG-C8-IQ (in Three Different Guanines of the *Nar*I Site) and dG-C8-3-ABA and Their Change in Percentages upon Knockdown of Specific Pols

  lesion        MF (%)   \% change in MF in pol η-deficient cells   \% change in MF in pol κ-deficient cells   \% change in MF in pol ι-deficient cells   \% change in MF in pol ζ-deficient cells   \% change in MF in Rev1-deficient cells   \% change in MF in (κ, ζ, and Rev1)-deficient cells
  ------------- -------- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ----------------------------------------- -----------------------------------------------------
  dG~1~-C8-IQ   17.8     +13                                        --43                                       --13                                       --6                                        --39                                      --93
  dG~2~-C8-IQ   24       +8                                         --68                                       --31                                       --50                                       --58                                      --99
  dG~3~-C8-IQ   50       +26                                        --36                                       --18                                       --26                                       --38                                      --96
  dG-C8-3-ABA   14       --39                                       +15                                        --29                                       +60                                        --61                                      [a](#t2fn1){ref-type="table-fn"}

Largest % change was noted with pol η and pol κ simultaneous knockdown, which gave 70% reduction in MF.

Upon simultaneous knockdown of pol κ, pol ζ, and Rev 1, a synergy was observed in that MF was reduced by more than 90% in each case ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). *In vitro* experiments using yeast pol ζ confirmed that it can extend the G~3~\*:A pair more efficiently than the G~3~\*:C pair, although it is inefficient at nucleotide incorporation opposite dG-C8-IQ. It is, therefore, conceivable that pol κ and pol ζ cooperatively carry out the majority of the error-prone TLS of dG-C8-IQ, whereas Rev1 may play a noncatalytic role in assembling the TLS pols. By contrast, pol η is involved mostly in its error-free bypass. Similar experiments have also been conducted with dG-C8--3-ABA,^[@ref136]^ the major DNA adduct formed by the carcinogen 3-nitrobenzanthrone (3-NBA) ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}).^[@ref137],[@ref138]^ Like dG-C8-IQ, dG-C8--3-ABA induces G → T as the major type of mutations in human cells.^[@ref136]^ However, the polymerase knockdown results are different. Pol η and pol κ were found to be the major contributors of the mutagenic TLS of dG-C8--3-ABA since MF dropped by 70%, when these pols were simultaneously knocked down, although MF actually increased upon knockdown of pol κ alone. In contrast, pol ζ is involved in the error-free bypass of the lesion since MF increased by 60% in pol ζ knockdown cells. A recent *in vitro* presteady state kinetic investigation showed that hpol η and hpol κ efficiently bypassed a site-specifically placed dG-C8--3-ABA, whereas hpol ι and hRev1 were severely stalled by the lesion.^[@ref139]^ Crystal structure analysis of dG-C8--3-ABA at the insertion stage of hpol η showed that the adduct is wedged at the hydrophobic cleft in the active site in *anti* conformation stabilized by a hydrogen bond between the C8 amino group and the phosphate, while the 2′-deoxyribose adopts C3′-*endo* pucker.^[@ref140]^ This structure provides a model for an accurate but slow bypass of the adduct by pol η. The structure of an erroneous bypass of dG-C8--3-ABA by a pol is yet to be solved. We postulate that both pol κ and pol ζ conduct error-free TLS of dG-C8--3-ABA. However, pol κ also extends mispairs generated by incorporation of dATP by pol η opposite the adduct. It is noteworthy that single-nucleotide incorporation opposite a dG-C8--3-ABA lesion catalyzed by hpol η *in vitro* showed that at short reaction time frames incorporation of dCTP is greater than dATP but that with longer time incorporation of these two nucleotides becomes comparable.^[@ref140]^ Rev1 likewise is important for mutagenesis, as reflected by 60% reduction in MF upon Rev1 knockdown, but as with dG-C8-IQ, it probably plays a noncatalytic role by physically interacting with the other two Y-family pols. The noncatalytic role of Rev1 was indicated by its inability to bypass the lesion *in vitro*. Therefore, the C8-dG adducts dG-C8-IQ and dG-C8--3-ABA do not behave the same way with different polymerases.

As mentioned earlier on the mechanism of frameshift mutations induced by dG-C8-AAF, many bulky adducts formed at the C8 position of dG, such as dG-C8-IQ and dG-C8--3-ABA, rotate the base to *syn* conformation, which is believed to play a structural role in frameshift mutations observed in bacteria.^[@ref141],[@ref142]^ More frequently in mammalian cells, however, these adducts induce base substitutions.^[@ref143],[@ref144]^ Since these purine lesions rotate to *syn* conformation, one can anticipate a role of pol ι in bypassing them, as this enzyme uses Hoogsteen base pairing to select the incoming nucleotide.^[@ref145]^ Pol ι can bypass only small dG-*N*^2^ adducts since *N*^2^ is oriented toward the major groove, and rotation to *syn* is inhibited for bulky dG-*N*^2^ adducts. In contrast, bulky dG-C8 adducts can be accommodated in the pol ι active site more efficiently. An example of pol ι's potential involvement in dG-C8 adduct bypass is its interaction with dG-C8-AP, the major adduct formed by the environmental carcinogen, 1-nitropyrene (1-NP) ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}). dG-C8-AP, like the other dG-C8 adduct mentioned earlier, induces predominantly G → T mutations in simian and human embryonic kidney cells.^[@ref144]^ The adduct, as other bulky dG-C8 adducts, exists in *syn* conformation in a base-displaced intercalated solution structure.^[@ref146],[@ref147]^ Replication of dG-C8-AP stalls when *in vitro* bypass is conducted by the TLS pols. Of the human TLS pols, hpol η is most proficient in bypassing it *in vitro*, but hpol κ and hpol ι can incorporate a nucleotide opposite the lesion.^[@ref148],[@ref149]^ Crystal structure analyses showed that dCTP incorporation opposite dG-C8-AP forces the adduct to rotate to the *anti* conformation to avoid steric hindrance at the minor groove side.^[@ref150]^ However, this structure inhibits further extension, due to a clash with the little finger domain of the enzyme. In contrast, the adduct can maintain *syn* conformation when dATP is inserted, in which the adenine is stacked above the pyrene ring intercalated in the helix. This structure allows further extension. Therefore, error-prone replication of dG-C8-AP potentially may occur by two TLS pols, with pol ι being involved in the insertion stage. Additional genetic evidence will be required to validate this pathway. Another dG-C8 adduct, (5′*S*)-8,5′-cyclo-dG, a cyclic DNA adduct containing a covalent bond between C8 of guanine and 5′ C of 2-deoxyribose, was investigated in human cells, which showed that pol η, pol ι, and pol ζ but not pol κ are involved in TLS.^[@ref151]^

Unlike the dG-*N*^2^ adducts, therefore, a pattern for TLS of the dG-C8 adducts could not be determined. For example, pol ζ is involved in extension of the correct pair of the dG-C8--3-ABA, whereas it extends the wrong pair with dG-C8-IQ.^[@ref135],[@ref136]^ Studies on additional dG-C8 adducts might give us a clue as to why they fail to follow a unifying mechanism of TLS.

4. Concluding Comments {#sec4}
======================

TLS of various DNA damages have been conducted principally by three complementary approaches. Genetic studies in repair and replication competent cells provide data on the outcome of the damage, and a comparison of these in genetically altered cells (including knockout or knockdown of specific genes) has been employed to investigate the role of each TLS pol. *In vitro* experiments using purified pols and accessory proteins elucidate how each pol can deal with the DNA damage, whereas structural and computational studies give a more intimate snapshot of the lesion bypass. Each approach has its limitations, and consequently, combined approaches are essential to comprehend the mechanism of TLS of a DNA lesion. Mechanistic information on replication of the DNA lesions is critical to follow the underlying process for the development of cancer, aging, and various other diseases. These fundamental studies are now paving the way to application of the acquired knowledge toward therapeutic application, as inhibiting the activity of some of the TLS pols may enhance the effect of an antitumor agent. As yet, more TLS work has been done with the pols from prokaryotes and archaea than from eukaryotes. It is certain that this dynamic area of research is still in its early stage and will continue to enrich the field of toxicology with many novel findings.
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TLS

:   translesion synthesis

PCNA

:   proliferating cell nuclear antigen

RPA

:   replication protein A

SHPRH

:   SNF2 histone-linker PHD-finger RING-finger helicase

HLTF

:   helicase-like transcription factor

MF

:   mutation frequency

HEK

:   human embryonic kidney

8-oxo-dG

:   7,8-dihydro-8-oxo-2′-deoxyguanosine

Fapy

:   formamidopyrimidine

Fapy·dG and MeFapy·dG

:   *N*^6^-(2-deoxy-[d]{.smallcaps}-*erythro*-pentofuranosyl)-2,6-diamino-3,4 dihydro-4-oxo-5-formamidopyrimidine) and its 5*N*-methyl derivative, respectively

N7-Me-dG

:   *N*7-methyl-2′-deoxyguanosine

*O*^6^-Me-dG

:   *O*^6^-methyl-2′-deoxyguanosine

CPD

:   *cis-syn* cyclobutane pyrimidine dimer

AFB~1~

:   aflatoxin B~1~

pol

:   DNA polymerase

BP

:   benzo\[*a*\]pyrene

BPDE

:   BP diol epoxide

IQ

:   2-amino-3-methylimidazo\[4,5-*f*\]quinoline

AAF

:   *N*-acetyl-2-aminofluorene

1-NP

:   1-nitropyrene

AP

:   aminopyrene

MC

:   mitomycin C

2,7-DAM

:   2,7-diaminomitosene

3-NBA

:   3-nitrobenzanthrone

3-ABA

:   3-aminobenzanthrone
